Literature DB >> 25766590

Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia.

Shanu Markand1, Alan Saul2, Penny Roon3, Puttur Prasad4, Pamela Martin5, Rima Rozen6, Vadivel Ganapathy5, Sylvia B Smith7.   

Abstract

PURPOSE: Methylenetetrahydrofolate reductase (Mthfr) is a key enzyme in homocysteine-methionine metabolism. We investigated Mthfr expression in retina and asked whether mild hyperhomocysteinemia, due to Mthfr deficiency, alters retinal neurovascular structure and function.
METHODS: Expression of Mthfr was investigated at the gene and protein level using quantitative (q) RT-PCR, in situ hybridization, immunoblotting, and immunohistochemistry (IHC). The Mthfr+/+ and Mthfr+/- mice were subjected to comprehensive evaluation using ERG, funduscopy, fluorescein angiography (FA), spectral-domain optical coherence tomography (SD-OCT), HPLC, and morphometric and IHC analysis of glial fibrillary acidic protein (GFAP) at 8 to 24 weeks.
RESULTS: Gene and protein analyses disclosed widespread retinal expression of Mthfr. Electroretinography (ERG) revealed a significant decrease in positive scotopic threshold response in retinas of Mthfr+/- mice at 24 weeks. Fundus examination in mice from both groups was normal; FA revealed areas of focal vascular leakage in 20% of Mthfr+/- mice at 12 to 16 weeks and 60% by 24 weeks. The SD-OCT revealed a significant decrease in nerve fiber layer (NFL) thickness at 24 weeks in Mthfr+/- compared to Mthfr+/+ mice. There was a 2-fold elevation in retinal hcy at 24 weeks in Mthfr+/- mice by HPLC and IHC. Morphometric analysis revealed an approximately 20% reduction in cells in the ganglion cell layer of Mthfr+/- mice at 24 weeks. The IHC indicated significantly increased GFAP labeling suggestive of Müller cell activation.
CONCLUSIONS: Mildly hyperhomocysteinemic Mthfr+/- mice demonstrate reduced ganglion cell function, thinner NFL, and mild vasculopathy by 24 weeks. The retinal phenotype is similar to that of hyperhomocysteinemic mice with deficiency of cystathionine-β-synthase (Cbs) reported earlier. The data support the hypothesis that hyperhomocysteinemia may be causative in certain retinal neurovasculopathies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25766590      PMCID: PMC4416541          DOI: 10.1167/iovs.14-16190

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  47 in total

1.  Homocysteine in sickle cell disease: relationship to stroke.

Authors:  P E Houston; S Rana; S Sekhsaria; E Perlin; K S Kim; O L Castro
Journal:  Am J Med       Date:  1997-09       Impact factor: 4.965

Review 2.  Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor.

Authors:  K Q Do; P L Herrling; P Streit; M Cuénod
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Analysis of the 677 C-->T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups.

Authors:  R F Franco; A G Araújo; J F Guerreiro; J Elion; M A Zago
Journal:  Thromb Haemost       Date:  1998-01       Impact factor: 5.249

4.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Folate-responsive optic neuropathy.

Authors:  K C Golnik; E R Schaible
Journal:  J Neuroophthalmol       Date:  1994-09       Impact factor: 3.042

6.  Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients.

Authors:  F P van der Dijs; J J Schnog; D A Brouwer; H J Velvis; G A van den Berg; A J Bakker; A J Duits; F D Muskiet; F A Muskiet
Journal:  Am J Hematol       Date:  1998-11       Impact factor: 10.047

7.  Homocysteine levels and the risk of osteoporotic fracture.

Authors:  Joyce B J van Meurs; Rosalie A M Dhonukshe-Rutten; Saskia M F Pluijm; Marjolein van der Klift; Robert de Jonge; Jan Lindemans; Lisette C P G M de Groot; Albert Hofman; Jacqueline C M Witteman; Johannes P T M van Leeuwen; Monique M B Breteler; Paul Lips; Huibert A P Pols; André G Uitterlinden
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

8.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

9.  Association of neovascular age-related macular degeneration and hyperhomocysteinemia.

Authors:  Ruth Axer-Siegel; Dan Bourla; Rita Ehrlich; Gad Dotan; Yoav Benjamini; Slava Gavendo; Dov Weinberger; Ben-Ami Sela
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

10.  Homocysteine metabolism in pregnancies complicated by neural-tube defects.

Authors:  J L Mills; J M McPartlin; P N Kirke; Y J Lee; M R Conley; D G Weir; J M Scott
Journal:  Lancet       Date:  1995-01-21       Impact factor: 79.321

View more
  16 in total

1.  Detailed electroretinographic findings in rd8 mice.

Authors:  Alan B Saul; Xuezhi Cui; Shanu Markand; Sylvia B Smith
Journal:  Doc Ophthalmol       Date:  2017-03-27       Impact factor: 2.379

2.  Homocysteine mediates transcriptional changes of the inflammatory pathway signature genes in human retinal pigment epithelial cells.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

3.  Effect of long-term chronic hyperhomocysteinemia on retinal structure and function in the cystathionine-β-synthase mutant mouse.

Authors:  Haiyan Xiao; Jing Wang; Shannon R Barwick; Yisang Yoon; Sylvia B Smith
Journal:  Exp Eye Res       Date:  2021-12-11       Impact factor: 3.770

4.  RetFM-J, an ImageJ-based module for automated counting and quantifying features of nuclei in retinal whole-mounts.

Authors:  Adam Hedberg-Buenz; Mark A Christopher; Carly J Lewis; Kacie J Meyer; Danielle S Rudd; Laura M Dutca; Kai Wang; Mona K Garvin; Todd E Scheetz; Michael D Abràmoff; Matthew M Harper; Michael G Anderson
Journal:  Exp Eye Res       Date:  2015-08-14       Impact factor: 3.467

5.  Mthfr as a modifier of the retinal phenotype of Crb1(rd8/rd8) mice.

Authors:  Shanu Markand; Alan Saul; Amany Tawfik; Xuezhi Cui; Rima Rozen; Sylvia B Smith
Journal:  Exp Eye Res       Date:  2015-12-02       Impact factor: 3.467

6.  Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration.

Authors:  Jing Wang; Alan Saul; Penny Roon; Sylvia B Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

7.  Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells.

Authors:  Soumya Navneet; Xuezhi Cui; Jing Zhao; Jing Wang; Navneet Ammal Kaidery; Bobby Thomas; Kathryn E Bollinger; Yisang Yoon; Sylvia B Smith
Journal:  Exp Eye Res       Date:  2018-03-31       Impact factor: 3.467

8.  Expression Analysis of the Circular RNA Molecules in the Human Retinal Cells Treated with Homocysteine.

Authors:  Mahavir Singh; Akash K George; Rubens Petit Homme; Avisek Majumder; Anwesha Laha; Harpal S Sandhu; Suresh C Tyagi
Journal:  Curr Eye Res       Date:  2018-12-05       Impact factor: 2.424

9.  Plasma homocysteine and macular thickness in older adults-the Rugao Longevity and Aging Study.

Authors:  Hui Zhang; Hangqi Shen; Wei Gong; Xuehui Sun; Xiaoyan Jiang; Jiucun Wang; Li Jin; Xun Xu; Dawei Luo; Xiaofeng Wang
Journal:  Eye (Lond)       Date:  2021-05-11       Impact factor: 4.456

10.  Role of Sigma 1 Receptor in Retinal Degeneration of the Ins2Akita/+ Murine Model of Diabetic Retinopathy.

Authors:  Jing Wang; Xuezhi Cui; Penny Roon; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-05-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.